3-142512266-A-G
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001184.4(ATR):c.4846T>C(p.Ser1616Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000076 in 1,579,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1616A) has been classified as Uncertain significance.
Frequency
Consequence
NM_001184.4 missense
Scores
Clinical Significance
Conservation
Publications
- Seckel syndrome 1Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Illumina, G2P, Ambry Genetics
- sarcomaInheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
- familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndromeInheritance: Unknown, AD Classification: MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
- Seckel syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- familial prostate carcinomaInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000670 AC: 1AN: 149288Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251050 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.00000769 AC: 11AN: 1429902Hom.: 0 Cov.: 35 AF XY: 0.00000982 AC XY: 7AN XY: 712764 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000670 AC: 1AN: 149288Hom.: 0 Cov.: 32 AF XY: 0.0000138 AC XY: 1AN XY: 72686 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The p.S1616P variant (also known as c.4846T>C), located in coding exon 27 of the ATR gene, results from a T to C substitution at nucleotide position 4846. The serine at codon 1616 is replaced by proline, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The proline amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. ClinVar contains an entry for this variant (Variation ID: 835654). This variant has not been reported in the literature in individuals affected with ATR-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.0009%). This sequence change replaces serine, which is neutral and polar, with proline, which is neutral and non-polar, at codon 1616 of the ATR protein (p.Ser1616Pro). -
Familial cutaneous telangiectasia and oropharyngeal predisposition cancer syndrome Uncertain:1
- -
Seckel syndrome 1 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at